1
16
At a meeting of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee, a voting member admitted he wasn’t sure about the COVID shot’s long-term risk to children despite the committee voting to recommend the Pfizer vaccine for kids ages 5-11.
The committee considered a voting question that read, “Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 Vaccine when administered as a 2-dose series … outweigh its risks for use in children 5-11 years of age?”
While considering the question, one member openly admitted they couldn’t be certain the vaccine is safe while advocating for children to be injected with it, saying, “We’re never going to learn about how safe the vaccine is until we start giving it.”